Bausch Health Companies Inc (BHC)

$6.10 -0.08 (-1.29%)
Market Cap 2.29B
Revenue (ttm) 9.63B
Net Income (ttm) -46.00M
EPS (ttm) N/A
PE Ratio 1.65
Forward PE 1.57
Profit Margin -0.48%
Debt to Equity Ratio -89.63
Volume 2,306,600
Avg Vol 2,448,312
Day's Range N/A - N/A
Shares Out 370.08M
Stochastic %K 86%
Beta 0.28
Analysts Hold
Price Target $7.08

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segm...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 514 744 6792
Address:
2150 St. ElzEar Boulevard West, Laval, Canada
williedaniel_
williedaniel_ Jun. 23 at 4:18 PM
$GEAT momo still asleep that is literal gift $BHC
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 4:05 PM
$BHC $4.53 to 6.15 bam out on insider selling
1 · Reply
kamryn_jackson
kamryn_jackson Jun. 20 at 3:31 PM
$BHC
0 · Reply
tregninnaw
tregninnaw Jun. 20 at 2:34 PM
$BHC what are the odds of Icahn, Paulsen, etc taking BHC private? Can they force the common shareholder to give up our shares at any price they set?
1 · Reply
carsonhuffman49
carsonhuffman49 Jun. 20 at 1:27 PM
$BHC
0 · Reply
amda
amda Jun. 20 at 12:33 PM
$BHC should be a mover today....
1 · Reply
MarkeTimer
MarkeTimer Jun. 18 at 10:04 PM
$BHC Heading much higher
1 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 18 at 9:01 PM
Bausch Health ($BHC) subsidiary upsizes debt offering to €675M while expanding term loan to $2.325B. Refinancing existing debt at higher rates (SOFR+4.25%) as negative equity persists. More debt piled on shaky foundation - liquidity patch comes with long-term cost. https://www.sec.gov/Archives/edgar/data/885590/000095010325007605/dp229898_8k.htm
1 · Reply
amda
amda Jun. 18 at 7:14 PM
$BHC Paulson pays 5.94 and this is still only 6.20? lol - he didn't buy for a move to 6.20 - he's thinking much, much higher....
0 · Reply
amda
amda Jun. 18 at 7:08 PM
$BHC According to filings by the Canadian-American pharmaceutical company, Nonexecutive Chairperson John Paulson acquired about 3.6 million shares at an average price of $5.94 apiece. At that price, the value of Paulson's latest share purchase is about $21.2 million. His total holdings are now 32.8 million shares in the company.
0 · Reply
Latest News on BHC
A Billionaire Trump Supporter Is Buying These Two Stocks

Jun 22, 2025, 5:00 AM EDT - 2 days ago

A Billionaire Trump Supporter Is Buying These Two Stocks

PPTA

Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares

Jun 18, 2025, 11:01 AM EDT - 5 days ago

Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares

Repricing Potential Driven By Deleveraging

Jun 16, 2025, 4:04 AM EDT - 8 days ago

Repricing Potential Driven By Deleveraging

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

Jun 4, 2025, 6:59 AM EDT - 20 days ago

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma

May 21, 2025, 9:45 AM EDT - 4 weeks ago

Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

May 21, 2025, 6:59 AM EDT - 4 weeks ago

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

Bausch Health Announces 2025 Annual Meeting of Shareholder Results

May 14, 2025, 4:15 PM EDT - 5 weeks ago

Bausch Health Announces 2025 Annual Meeting of Shareholder Results

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

May 14, 2025, 6:59 AM EDT - 5 weeks ago

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

May 7, 2025, 7:00 AM EDT - 6 weeks ago

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

May 6, 2025, 8:00 AM EDT - 7 weeks ago

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 7:51 PM EDT - 7 weeks ago

Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript

Bausch Health Announces First Quarter 2025 Results

Apr 30, 2025, 4:05 PM EDT - 7 weeks ago

Bausch Health Announces First Quarter 2025 Results

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

Apr 29, 2025, 8:00 AM EDT - 2 months ago

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Apr 22, 2025, 9:33 AM EDT - 2 months ago

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Bausch Health says Carl Icahn has exposure to about 34% of company's shares

Apr 22, 2025, 8:54 AM EDT - 2 months ago

Bausch Health says Carl Icahn has exposure to about 34% of company's shares

Bausch Health Announces Filing of Supplement to Proxy Statement

Apr 22, 2025, 7:25 AM EDT - 2 months ago

Bausch Health Announces Filing of Supplement to Proxy Statement

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Apr 21, 2025, 7:00 AM EDT - 2 months ago

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

Apr 17, 2025, 3:40 PM EDT - 2 months ago

U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

Bausch Health Announces Adoption of Shareholder Rights Plan

Apr 14, 2025, 4:30 PM EDT - 2 months ago

Bausch Health Announces Adoption of Shareholder Rights Plan

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Apr 10, 2025, 4:15 PM EDT - 2 months ago

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

Apr 9, 2025, 8:00 AM EDT - 2 months ago

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity

Apr 5, 2025, 3:00 AM EDT - 2 months ago

Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Apr 2, 2025, 8:00 AM EDT - 2 months ago

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch + Lomb recalls some of its implantable eye lenses

Mar 27, 2025, 8:44 AM EDT - 3 months ago

Bausch + Lomb recalls some of its implantable eye lenses

Bausch + Lomb Recalls EnVista Intraocular Lenses

Mar 27, 2025, 7:30 AM EDT - 3 months ago

Bausch + Lomb Recalls EnVista Intraocular Lenses

Bausch Health to Announce First Quarter Results on April 30

Mar 27, 2025, 7:00 AM EDT - 3 months ago

Bausch Health to Announce First Quarter Results on April 30

Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses

Mar 27, 2025, 7:00 AM EDT - 3 months ago

Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 26, 2025, 7:07 AM EDT - 3 months ago

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

CHWY

Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

Mar 25, 2025, 2:00 PM EDT - 3 months ago

Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

Bausch Health Announces Conditional Redemption of Senior Notes

Mar 21, 2025, 4:15 PM EDT - 3 months ago

Bausch Health Announces Conditional Redemption of Senior Notes

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Mar 19, 2025, 11:45 AM EDT - 3 months ago

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

Mar 19, 2025, 11:45 AM EDT - 3 months ago

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

Mar 14, 2025, 9:25 AM EDT - 3 months ago

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

Bausch Health Companies Inc. (BHC) J.P. Morgan Global Leveraged Finance Conference Transcript

Feb 24, 2025, 10:43 AM EST - 4 months ago

Bausch Health Companies Inc. (BHC) J.P. Morgan Global Leveraged Finance Conference Transcript

Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room

Feb 21, 2025, 1:33 PM EST - 4 months ago

Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room

Bausch Health Q4 Earnings Recap (Reiterating Buy Rating)

Feb 20, 2025, 6:01 PM EST - 4 months ago

Bausch Health Q4 Earnings Recap (Reiterating Buy Rating)

Bausch Health Companies Inc. (BHC) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 8:28 PM EST - 4 months ago

Bausch Health Companies Inc. (BHC) Q4 2024 Earnings Call Transcript

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

Feb 19, 2025, 4:05 PM EST - 4 months ago

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

Feb 19, 2025, 6:58 AM EST - 4 months ago

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Feb 14, 2025, 8:00 AM EST - 4 months ago

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

Feb 12, 2025, 5:41 AM EST - 4 months ago

Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Feb 10, 2025, 8:00 AM EST - 4 months ago

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Contact lens maker Bausch + Lomb rules out take-private deal

Feb 6, 2025, 7:27 AM EST - 4 months ago

Contact lens maker Bausch + Lomb rules out take-private deal

Bausch Health Provides Update on Strategic Alternatives

Feb 6, 2025, 7:05 AM EST - 4 months ago

Bausch Health Provides Update on Strategic Alternatives

BLCO

Bausch + Lomb Provides Update on Potential Sale

Feb 6, 2025, 7:00 AM EST - 4 months ago

Bausch + Lomb Provides Update on Potential Sale

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Jan 23, 2025, 7:00 AM EST - 5 months ago

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Jan 22, 2025, 7:00 AM EST - 5 months ago

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Jan 17, 2025, 9:25 AM EST - 5 months ago

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Bausch + Lomb CEO on the negative impact of screen time on eye health

Jan 14, 2025, 2:15 PM EST - 5 months ago

Bausch + Lomb CEO on the negative impact of screen time on eye health

Bausch and Lomb CEO: Right on track with our important initiatives

Jan 14, 2025, 12:24 PM EST - 5 months ago

Bausch and Lomb CEO: Right on track with our important initiatives

williedaniel_
williedaniel_ Jun. 23 at 4:18 PM
$GEAT momo still asleep that is literal gift $BHC
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 4:05 PM
$BHC $4.53 to 6.15 bam out on insider selling
1 · Reply
kamryn_jackson
kamryn_jackson Jun. 20 at 3:31 PM
$BHC
0 · Reply
tregninnaw
tregninnaw Jun. 20 at 2:34 PM
$BHC what are the odds of Icahn, Paulsen, etc taking BHC private? Can they force the common shareholder to give up our shares at any price they set?
1 · Reply
carsonhuffman49
carsonhuffman49 Jun. 20 at 1:27 PM
$BHC
0 · Reply
amda
amda Jun. 20 at 12:33 PM
$BHC should be a mover today....
1 · Reply
MarkeTimer
MarkeTimer Jun. 18 at 10:04 PM
$BHC Heading much higher
1 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 18 at 9:01 PM
Bausch Health ($BHC) subsidiary upsizes debt offering to €675M while expanding term loan to $2.325B. Refinancing existing debt at higher rates (SOFR+4.25%) as negative equity persists. More debt piled on shaky foundation - liquidity patch comes with long-term cost. https://www.sec.gov/Archives/edgar/data/885590/000095010325007605/dp229898_8k.htm
1 · Reply
amda
amda Jun. 18 at 7:14 PM
$BHC Paulson pays 5.94 and this is still only 6.20? lol - he didn't buy for a move to 6.20 - he's thinking much, much higher....
0 · Reply
amda
amda Jun. 18 at 7:08 PM
$BHC According to filings by the Canadian-American pharmaceutical company, Nonexecutive Chairperson John Paulson acquired about 3.6 million shares at an average price of $5.94 apiece. At that price, the value of Paulson's latest share purchase is about $21.2 million. His total holdings are now 32.8 million shares in the company.
0 · Reply
amda
amda Jun. 18 at 6:14 PM
$BHC good post bt. Paulson is not dumb money.....
0 · Reply
btradingwarehouse
btradingwarehouse Jun. 18 at 6:12 PM
$BHC ...2BULLS... ... An unsolicited advice to my fellow BULLS ( newbies !!!) Be VERY careful with your entries This price action does NOT reflect anything !!! but pure play of those using this Beauty for hedging and tax ... @BHC is supposed to be ~$ 34-40.00 This is a superb Co. that set me ~$400K in red for years !!! (I am still in and will never exit-see my previous posts) ... ADVICE: Do NOT rush it in !!! When this beauty starts going up you will have plenty of time to measure your entries ... Meantime stay smart strong smile Be nice to bears ALL GOOD
0 · Reply
Winning_calls
Winning_calls Jun. 18 at 4:33 PM
$BHC 🤞🤞
0 · Reply
Bobberty
Bobberty Jun. 18 at 4:23 PM
$BHC lmao, didn't think I'd ever say "wish I'd bought more BHC".
0 · Reply
amda
amda Jun. 18 at 4:22 PM
$BHC follow the money....
0 · Reply
Winning_calls
Winning_calls Jun. 18 at 2:14 PM
$BHC let's 👊👊
0 · Reply
RonIsWrong
RonIsWrong Jun. 18 at 2:12 PM
$BHC 👀
0 · Reply
topstockalerts
topstockalerts Jun. 18 at 1:45 PM
$BHC setting up nicely..🏦📈🏦
0 · Reply
copywrites
copywrites Jun. 18 at 1:43 PM
$BHC nice blocks being bought by the way... someone wants shares
0 · Reply
deerix
deerix Jun. 18 at 1:04 PM
$BHC Fuck, why did nobody tell me about this stock sub 5.
0 · Reply
hkm_trader
hkm_trader Jun. 18 at 12:18 PM
$BHC what really did ackman do to this $SPY
0 · Reply
J2sun
J2sun Jun. 18 at 3:07 AM
$BHC Paulson buying over 21M in stock https://www.tradingview.com/news/mtnewswires.com:20250617:A3397803:0/
0 · Reply